Pamela B. Morris

5.8k total citations · 6 hit papers
49 papers, 3.2k citations indexed

About

Pamela B. Morris is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Pamela B. Morris has authored 49 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 18 papers in Cardiology and Cardiovascular Medicine and 12 papers in Physiology. Recurrent topics in Pamela B. Morris's work include Lipoproteins and Cardiovascular Health (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Pamela B. Morris is often cited by papers focused on Lipoproteins and Cardiovascular Health (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Pamela B. Morris collaborates with scholars based in United States, Netherlands and Germany. Pamela B. Morris's co-authors include Kim K. Birtcher, Christie M. Ballantyne, Carl E. Orringer, Donald M. Lloyd‐Jones, Sondra M. DePalma, Margo Minissian, David D. Daly, Sidney C. Smith, Salim S. Virani and Barbara S. Wiggins and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

Pamela B. Morris

46 papers receiving 3.1k citations

Hit Papers

2016 ACC Expert Consensus... 2016 2026 2019 2022 2016 2020 2022 2017 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    2016 355 citations Donald M. Lloyd‐Jones, Pamela B. Morris et al. Journal of the American College of Cardiology profile →
  2. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
    2020 292 citations Kim K. Birtcher, Mikhail Kosiborod et al. Journal of the American College of Cardiology profile →
  3. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    2022 290 citations Donald M. Lloyd‐Jones, Pamela B. Morris et al. Journal of the American College of Cardiology profile →
  4. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
    2017 280 citations Donald M. Lloyd‐Jones, Pamela B. Morris et al. Journal of the American College of Cardiology profile →
  5. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
    2016 239 citations Barbara S. Wiggins, Joseph J. Saseen et al. Circulation profile →
  6. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
    2021 167 citations Salim S. Virani, Pamela B. Morris et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela B. Morris United States 24 1.4k 1.0k 929 557 375 49 3.2k
Nina P. Paynter United States 29 1.1k 0.8× 1.3k 1.2× 928 1.0× 376 0.7× 442 1.2× 69 4.1k
Sarah Parish United Kingdom 33 1.4k 0.9× 1.2k 1.2× 959 1.0× 270 0.5× 434 1.2× 84 3.9k
Stephen D. Wiviott United States 28 1.6k 1.1× 1.4k 1.4× 1.4k 1.5× 464 0.8× 287 0.8× 68 3.5k
Carl E. Orringer United States 24 2.4k 1.7× 1.0k 1.0× 1.2k 1.3× 787 1.4× 267 0.7× 55 3.7k
Jane Armitage United Kingdom 11 1.8k 1.3× 961 0.9× 1.5k 1.6× 514 0.9× 239 0.6× 29 3.4k
David S Wald United Kingdom 23 2.0k 1.4× 1.8k 1.8× 577 0.6× 494 0.9× 363 1.0× 60 5.0k
Charalambos Vlachopoulos Greece 6 2.4k 1.7× 1.2k 1.1× 1.2k 1.3× 809 1.5× 184 0.5× 10 3.5k
David A. DeMicco United States 33 2.6k 1.8× 1.5k 1.5× 1.8k 2.0× 600 1.1× 459 1.2× 69 4.5k
Margaret J. Thomason United Kingdom 19 1.9k 1.3× 744 0.7× 1.8k 1.9× 691 1.2× 229 0.6× 32 3.6k
Milan Gupta Canada 30 1.2k 0.8× 1.4k 1.4× 619 0.7× 292 0.5× 560 1.5× 91 4.1k

Countries citing papers authored by Pamela B. Morris

Since Specialization
Citations

This map shows the geographic impact of Pamela B. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela B. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela B. Morris more than expected).

Fields of papers citing papers by Pamela B. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela B. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela B. Morris. The network helps show where Pamela B. Morris may publish in the future.

Co-authorship network of co-authors of Pamela B. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela B. Morris. A scholar is included among the top collaborators of Pamela B. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela B. Morris. Pamela B. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spitz, Jared, Anandita Agarwala, Garima Sharma, et al.. (2025). A Critical Appraisal of Lipid Management in the Post-Statin Era. JACC Advances. 4(6). 101823–101823.
2.
3.
Khan, Safi U., Ahmad Naeem Lone, Neal S. Kleiman, et al.. (2023). Aspirin With or Without Statin in Individuals Without Atherosclerotic Cardiovascular Disease Across Risk Categories. JACC Advances. 2(2). 100197–100197. 6 indexed citations
4.
Rifai, Mahmoud Al, Moysés Szklo, Jaideep Patel, et al.. (2022). Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). The American Journal of Cardiology. 184. 7–13. 1 indexed citations
5.
Lloyd‐Jones, Donald M., Pamela B. Morris, Christie M. Ballantyne, et al.. (2022). 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Journal of the American College of Cardiology. 80(14). 1366–1418. 290 indexed citations breakdown →
6.
Kris‐Etherton, Penny M., Kristina H. Petersen, Jean‐Pierre Després, et al.. (2021). Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association. Circulation. 144(24). e495–e514. 62 indexed citations
7.
Nahhas, Georges J., K. Michael Cummings, Michael J. Halenar, et al.. (2021). Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1–4. Preventive Medicine Reports. 25. 101650–101650. 7 indexed citations
8.
Rifai, Mahmoud Al, Sahar Naderi, Rubina Barolia, et al.. (2020). Association of Smokeless Tobacco Use With the Use of Other Illicit Drugs in the United States. The American Journal of Medicine. 134(1). e15–e19. 3 indexed citations
9.
Shapiro, Michael D., David J. Maron, Pamela B. Morris, et al.. (2019). Preventive Cardiology as a Subspecialty of Cardiovascular Medicine. Journal of the American College of Cardiology. 74(15). 1926–1942. 25 indexed citations
10.
Virani, Salim S., Julia M. Akeroyd, Vijay Nambi, et al.. (2018). Applicability and Cost Implications for PCKS9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights from the Department of Veterans Affairs. Circulation. 3 indexed citations
11.
Freeman, Andrew M., Pamela B. Morris, Karen Aspry, et al.. (2018). A Clinician’s Guide for Trending Cardiovascular Nutrition Controversies. Journal of the American College of Cardiology. 72(5). 553–568. 26 indexed citations
12.
Kates, Andrew M., Pamela B. Morris, Athena Poppas, & Jeffrey T. Kuvin. (2018). Impact of Live, Scientific Annual Meetings in Today’s Cardiovascular World. Journal of the American College of Cardiology. 72(17). 2082–2085. 4 indexed citations
13.
Barua, Rajat S., Nancy A. Rigotti, Neal L. Benowitz, et al.. (2018). 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment. Journal of the American College of Cardiology. 72(25). 3332–3365. 197 indexed citations
14.
Freeman, Andrew M., Pamela B. Morris, Neal D. Barnard, et al.. (2017). Trending Cardiovascular Nutrition Controversies. Journal of the American College of Cardiology. 69(9). 1172–1187. 103 indexed citations
15.
Rosenson, Robert S., Steven K. Baker, Maciej Banach, et al.. (2017). Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Journal of the American College of Cardiology. 70(10). 1290–1301. 132 indexed citations
16.
Lloyd‐Jones, Donald M., Pamela B. Morris, Christie M. Ballantyne, et al.. (2017). 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Journal of the American College of Cardiology. 70(14). 1785–1822. 280 indexed citations breakdown →
17.
Wiggins, Barbara S., Joseph J. Saseen, Robert L. Page, et al.. (2016). Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 134(21). e468–e495. 239 indexed citations breakdown →
18.
Lloyd‐Jones, Donald M., Pamela B. Morris, Christie M. Ballantyne, et al.. (2016). 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Journal of the American College of Cardiology. 68(1). 92–125. 355 indexed citations breakdown →
19.
Tesche, Christian, Carlo N. De Cecco, Rozemarijn Vliegenthart, et al.. (2016). Accuracy and Radiation Dose Reduction Using Low-Voltage Computed Tomography Coronary Artery Calcium Scoring With Tin Filtration. The American Journal of Cardiology. 119(4). 675–680. 29 indexed citations
20.
Morris, Pamela B., Christie M. Ballantyne, Kim K. Birtcher, Steven P. Dunn, & Elaine M. Urbina. (2014). Review of Clinical Practice Guidelines for the Management of LDL-Related Risk. Journal of the American College of Cardiology. 64(2). 196–206. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina P. Paynter Breakdown of academic impact, for papers by Sarah Parish Breakdown of academic impact, for papers by Stephen D. Wiviott Breakdown of academic impact, for papers by Carl E. Orringer Breakdown of academic impact, for papers by Jane Armitage Breakdown of academic impact, for papers by David S Wald Breakdown of academic impact, for papers by Charalambos Vlachopoulos Breakdown of academic impact, for papers by David A. DeMicco Breakdown of academic impact, for papers by Margaret J. Thomason Breakdown of academic impact, for papers by Milan Gupta
Rankless by CCL
2026